REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $36,000 | -16.3% | 2,597 | +17.4% | 0.00% | – |
Q1 2022 | $43,000 | 0.0% | 2,213 | -16.9% | 0.00% | – |
Q4 2021 | $43,000 | -17.3% | 2,662 | +42.0% | 0.00% | – |
Q3 2021 | $52,000 | -7.1% | 1,874 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $56,000 | -15.2% | 1,874 | -21.1% | 0.00% | 0.0% |
Q1 2021 | $66,000 | +34.7% | 2,374 | +36.3% | 0.00% | 0.0% |
Q4 2020 | $49,000 | +11.4% | 1,742 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $44,000 | 0.0% | 1,742 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $44,000 | +1366.7% | 1,742 | +771.0% | 0.00% | – |
Q3 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | – |
Q4 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $6,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |